Kissei Pharmaceutical: Announcement of the new sale of the uterine fibroid treatment drug Iserti (generic name Linzagolix) in Europe

JPX · Sep 17 07:45

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.